Neither peptide "wins" outright because they act on different phases of the repair cascade rather than competing: for localised tendon and ligament models, BPC-157 has the stronger preclinical evidence (early-phase angiogenesis and growth-factor signalling)
We find this practice misleading
CrossRef The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: understanding inequalities in prevalence and outcomes Dominika Lorek, Krzysztof upina, Wiktoria Bisaga, Dominik Malicki, Weronika Stpie, Laura Kumor, Jakub Janczura Korean Journal of Family Medicine .2025
Grant (2019): Demonstrated rapid uptake of NAD injections
Chief Medical Officer Phoebe Fox is a pharmacist independent prescriber with a diverse background in community pharmacy, primary care, and digital health